EURONEXT-AMS$PHG
Koninklijke Philips N.V. · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
Comparable sales up 3% as adjusted EBITA margin expands 50 bps to 12.3%
Royal Philips reported Q3 2025 group sales of €4.3 billion with 3% comparable sales growth and 8% comparable order intake growth. Income from operations was €330 million and adjusted EBITA increased to €531 million, lifting the margin 50 basis points to 12.3%. Net income was €187 million with diluted EPS of €0.19 and adjusted diluted EPS from continuing operations of €0.36. Free cash flow was €172 million and productivity savings reached €222 million in the quarter. All three segments grew comparably—Personal Health up 11%, Connected Care up 5%, Diagnosis & Treatment up 1%—and Philips reiterated full-year 2025 guidance with adjusted EBITA margin now expected toward the upper end of the 11.3–11.8% range.
- Group sales €4.30B with 3% comparable growth and 8% comparable order intake growth
- Adjusted EBITA €531M; margin expanded 50 bps to 12.3%
- Net income €187M; adjusted diluted EPS €0.36 from continuing operations
- Free cash flow €172M; €222M productivity savings in the quarter
- Full-year adjusted EBITA margin outlook now toward upper end of 11.3–11.8% range
Headline financials
Revenue & EPS history
Philips · Revenue · Quarterly
€4.3B
Revenue by segment
Philips · €4.16B total across 3 segments · Q3 2025
- Diagnosis & Treatment€2.08B—50.0%
- Connected Care€1.2B—28.8%
- Personal Health€883M—21.2%
Forward guidance
Philips reiterated 2025 outlook for comparable sales growth of 1–3%, adjusted EBITA margin of 11.3–11.8% (now toward the upper end), and free cash flow of €0.2–0.4 billion.
Tailwinds
- Order intake and North America momentum support second-half execution
- Productivity program on track for €800M savings in 2025
Headwinds
- Tariffs weighed on segment margins, especially Diagnosis & Treatment
- Respironics-related charges and quality actions remain a drag
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2025
+0.5%
Avg return
Earnings day
-0.4%
Avg return
5 days after
-0.4%
Avg return
30 days after
58%
36 / 62 earnings
Positive
+26.0%
Q1 2024
Best reaction
-15.3%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.8% | -19.7% | -16.1% | |
| Q4 2025 | +11.1% | +5.5% | -4.6% | |
| Q3 2025 | +3.4% | +3.5% | -2.0% | |
| Q2 2025 | +7.2% | +3.1% | +7.5% | |
| Q4 2024 | -11.6% | -8.2% | -10.0% | |
| Q3 2024 | -15.3% | -16.4% | -14.3% | |
| Q1 2024 | +26.0% | +27.3% | +29.3% | |
| Q3 2023 | +3.1% | +1.4% | +16.1% | |
| Q2 2023 | -6.8% | -9.4% | -3.7% | |
| Q1 2023 | +10.2% | +11.0% | +2.4% | |
| Q4 2022 | +0.8% | +4.2% | -5.2% | |
| Q3 2022 | -0.6% | -3.3% | +9.3% | |
| Q2 2022 | -3.5% | -6.3% | -19.8% | |
| Q1 2022 | -14.3% | -15.0% | -18.4% | |
| Q4 2021 | +0.1% | -1.5% | +3.0% | |
| Q3 2021 | +0.8% | +7.9% | -7.3% | |
| Q2 2021 | -5.1% | -4.0% | -6.0% | |
| Q1 2021 | -6.3% | -7.3% | -6.4% | |
| Q4 2020 | +4.2% | -2.3% | +1.4% | |
| Q3 2020 | +4.8% | +2.6% | +6.2% | |
| Q2 2020 | +4.4% | +4.0% | +3.8% | |
| Q1 2020 | +2.0% | +5.1% | +9.8% | |
| Q4 2019 | -2.9% | -0.7% | +10.5% | |
| Q3 2019 | -2.5% | -7.5% | -14.8% | |
| Q2 2019 | +8.7% | -0.3% | -4.3% | |
| Q1 2019 | +6.1% | +3.0% | +10.0% | |
| Q4 2018 | +3.5% | -1.3% | -0.4% | |
| Q3 2018 | -9.0% | -9.1% | -7.3% | |
| Q2 2018 | -0.5% | +3.2% | +1.6% | |
| Q1 2018 | +4.0% | +5.3% | +4.1% | |
| Q4 2017 | -2.5% | -5.4% | -9.2% | |
| Q3 2017 | -3.4% | -2.1% | -5.7% | |
| Q2 2017 | +5.3% | +5.1% | +4.9% | |
| Q1 2017 | +6.2% | +5.4% | +8.5% | |
| Q4 2016 | -1.1% | -1.4% | -1.4% | |
| Q3 2016 | +4.2% | +6.2% | +3.7% | |
| Q2 2016 | +2.4% | +1.8% | +11.3% | |
| Q1 2016 | -2.2% | — | — | |
| Q4 2015 | +6.2% | — | — | |
| Q3 2015 | +0.5% | — | — | |
| Q2 2015 | +5.1% | — | — | |
| Q1 2015 | -3.8% | — | — | |
| Q4 2014 | -7.6% | — | — | |
| Q3 2014 | -1.6% | — | — | |
| Q2 2014 | +4.1% | — | — | |
| Q1 2014 | -6.5% | — | — | |
| Q4 2013 | -2.7% | — | — | |
| Q3 2013 | +6.2% | — | — | |
| Q2 2013 | +1.6% | — | — | |
| Q1 2013 | -0.5% | — | — | |
| Q4 2012 | -3.3% | — | — | |
| Q3 2012 | +0.3% | — | — | |
| Q2 2012 | +1.2% | — | — | |
| Q1 2012 | -1.0% | — | — | |
| Q4 2011 | +0.1% | — | — | |
| Q3 2011 | -9.6% | — | — | |
| Q2 2011 | +4.7% | — | — | |
| Q1 2011 | +1.2% | — | — | |
| Q4 2010 | -0.9% | — | — | |
| Q3 2010 | +0.5% | — | — | |
| Q2 2010 | +0.5% | — | — | |
| Q1 2010 | +2.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro